2016

Omnicare has been in the news for two separate cases recently, one involving a whistleblower suit, and another involving Abbott…

Twenty states have announced that they have filed a lawsuit against generic-drug makers including Heritage Pharmaceuticals Inc.,…

This article takes a fresh look at trends in changing norms of ethical behavior by senior management and the challenge for…

On November 15, 2016, the Centers for Medicare and Medicaid Services (CMS) released updated Medicare and Medicaid drug spending…

The Alliance for Health Reform recently held a Congressional briefing about cost growth of pharmaceuticals in the Medicare program…

Historically, medical affairs and marketing have directed both the generation and dissemination of information about their…

An article by reporters at Bloomberg recently highlighted the way United States prosecutors are beginning to crack down on generic…

In part three of our MACRA series, we look at the broader implications of this rule on the healthcare world. We are especially…

This article is a continuation of the previous article that discussed the first day of the 17th Annual Pharmaceutical and Medical…

In June 2016, at the AMA House of Delegates meeting in Chicago, one of the topics discussed was Maintenance of Certification.…